PDCD1 and neoplasm: In contrast to the PBS control group, which exhibited densely packed tumor cells with little necrosis, PD-1/Tim-3 nanovesicle treatment resulted in significantly reduced tumor cellularity and increased areas of necrosis, consistent with an effective anti-tumor immune response (Figure 4E).